ORIGINAL RESEARCH
Accepted on 28 Mar 2025
Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology
doi 10.3389/fphar.2025.1567639
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Metabolic Dysfunction-Associated Steatotic Liver Disease: From Targets to Therapeutic Strategies
Metabolic Dysfunction-Associated Steatotic Liver Disease: From Targets to Therapeutic Strategies
615
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.